We are committed to having a remarkable impact by going beyond medicines.
In efforts to ensure that our Grants and Donations have a greater impact and directly benefit patients, we must be more focused and strategic in our review process. In 2026, AbbVie Australia and New Zealand will only exclusively support initiatives that are aligned with AbbVie’s scientific focus areas and demonstrate a commitment to raising disease awareness, health equity, improving patient outcomes and access or advancing science and medical education.
We only accept applications at set times each year. Please submit your application by the closing dates below. Late applications will not be considered.
2026 Funding Application Closing Dates
Friday, 26th June
Friday, 16th October
What are AbbVie’s scientific areas of interest?
AbbVie’s scientific areas of interest include: rheumatology, dermatology, gastroenterology, hematology-oncology, solid tumors, urology, migraine, parkinson’s, spasticity and movement disorder, ophthalmology and hepatitis C.
For more information on applying for funding from AbbVie New Zealand download the AbbVie Funding Guide here.
Consider the following items when submitting your application:
AbbVie won’t support requests for:
Step 1: Registration
All requests for funding must be submitted through our online form, and at least 60 days before the start date of an activity.
You must:
Step 2: Application review and payment
AbbVie carefully considers every grant request. Criteria for awarding a grant includes but is not limited to:
We work to ensure that a decision will be made within four weeks of the application deadline. If you have questions, please contact [email protected]. If an application is incomplete or funding type does not match the original request, a Request for Additional Information (RFAI) will be sent to the requestor.
If your application is not successful, you will be sent an email notifying you of the outcome.
If approved, you will be sent an email confirmation with instructions to review and electronically sign the contractual agreement.
The contractual agreement must be signed by all parties, prior to the start date of the event to be considered a fully executed contract. Once signed you will receive an email requesting an invoice for payment.
Step 3: Reconciliation and outcomes
Reconciliation is required within 90 days after the completion of the program.
For more information on applying for funding from AbbVie New Zealand download the AbbVie Funding Guide here.
AbbVie New Zealand would like to acknowledge Māori and the unique position they hold as tangata whenua of Aotearoa New Zealand. We are committed to gaining a deeper understanding of Te Tiriti o Waitangi and aspire to being a great Tiriti partner so we can further support the advancement of health outcomes for Māori.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.